Three cases of rare salivary gland tumours: A molecular study of TP53, CDKN2A/ARF, RAS, BRAF, PTEN, MAPK2 and EGFR genes

Oncology Reports

Volumn 26, Issue 1, 2011, Pages 3-11

  Falbo, Vincenzo ^a   Floridia, Giovanna ^a   Censi, Federica ^a   Marra, Manuela ^a   Foschini, Maria P ^b   Taruscio, Domenica ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Molecular analysis; Rare tumours; Salivary gland tumours

Indexed keywords

ALANINE; GLUTAMIC ACID; ISOLEUCINE; VALINE;

ADENOID CYSTIC CARCINOMA; ADULT; AGED; AMINO ACID SUBSTITUTION; ARF GENE; ARTICLE; BRAF GENE; CANCER GRADING; CARCINOGENESIS; CASE REPORT; CDKN2A GENE; EGFR GENE; EXON; FEMALE; FRAMESHIFT MUTATION; GENE FUNCTION; GENE IDENTIFICATION; GENE INSERTION; GENE LOCUS; GENE SEQUENCE; GENOMIC INSTABILITY; HETEROZYGOSITY; HUMAN; MALE; MAPK2 GENE; MICROSATELLITE MARKER; MISSENSE MUTATION; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; ONCOGENE; ONCOGENE H RAS; ONCOGENE K RAS; ONCOGENE N RAS; ONCOGENE RAS; POINT MUTATION; PRIORITY JOURNAL; PTEN GENE; SINGLE NUCLEOTIDE POLYMORPHISM; TP53 GENE;

AGED; ALLELES; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; HUMANS; MALE; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASE 1; MODELS, GENETIC; MUTATION, MISSENSE; PROGNOSIS; PROTO-ONCOGENE PROTEINS B-RAF; PTEN PHOSPHOHYDROLASE; RAS PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SALIVARY GLAND NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79955854291     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1263     Document Type: Article

References (30)

1. Ferrario F, Roselli R and Spriano G: Epidemiologia e fattori di rischio. In: Relazione Ufficiale 'Tumori delle ghiandole salivari maggiori', XCV Congres so Nazionale, Società Italiana di Otorinolaringoiatria e Chirurgia Cervico-Facciale, Torino, 21-24 Maggio 2008, Spriano G (ed.) pp55-82, 2008.
2. Cheuk W and Chan JK: Advances in salivary gland pathology. Histopathology 51: 1-20, 2007. (Pubitemid 46976367)
3. Barnes L, Everson JW, Reichart P, et al: World Health Organization classification of tumours: pathology and genetics of head and neck tumours. IARC Press, Lyon, 2005.
4. Skalova A: Rare tumours of salivary glands. Pathol Case Rev 9: 264-269, 2004.
5. Dardick I: Guidelines for salivary gland tumours taxonomy. In: Salivary Gland Tumours Pathology. Igaku-Shoin, New York, NY, pp35-41, 1996.
6. Nagao T, Gaffey TA, Serizawa H, Sugano I, Ishida Y, Yamazaki K, Tokashiki R, Yoshida T, Minato H, Kay PA and Lewis JE: Dedifferentiated adenoid cystic carcinoma: a clinicopathologic study of 6 cases. Mod Pathol 16: 1265-1272, 2003. (Pubitemid 38018609)
7. Cheuk W, Chan JK and Ngan RK: Dedifferentiation in adenoid cystic carcinoma of salivary gland: an uncommon complication associated with an accelerated clinical course. Am J Surg Pathol 23: 465-472, 1999. (Pubitemid 29160008)
8. Seethala RR, Hunt JL, Baloch ZW, Livolsi VA and Leon Barnes E: Adenoid cystic carcinoma with high-grade transformation: a report of 11 cases and a review of the literature. Am J Surg Pathol 31: 1683-1694, 2007. (Pubitemid 350287566)
9. Seifert G and Donath K: Hybrid tumours of salivary glands: definition and classification of five rare cases. Eur J Cancer B Oral Oncol 32B: 251-259, 1996.
10. Nagao T, Sugano I, Ishida Y, Asoh A, Munakata S, Yamazaki K, Konno A, Iwaya K, Shimizu T, Serizawa H and Ebihara Y: Hybrid carcinomas of the salivary glands: report of nine cases with a clinicopathologic, immunohistochemical, and p53 gene alteration analysis. Mod Pathol 15: 724-733, 2002. (Pubitemid 34787308)
11. Ellis GL and Auclair PL: Tumours of the salivary glands. In: AFIP Atlas of Tumours Pathology, Series 4, Washington DC, 2008.
12. Dahse R, Berndt A and Kosmehl H: PCR-based testing for therapy-related EGFR mutations in patients with non-small cell lung cancer. Anticancer Res 28: 2265-2270, 2008.
13. Altschul SF, Gish W, Miller W, Myers EW and Lipman DJ: Basic local alignment search tool. JMB 214: 1-8, 1990.
14. INK4 CDK inhibitory activity. Int J Cancer 66: 249-254, 1996. (Pubitemid 26248209)
15. Hollstein M, Sidransky D, Vogelstein B and Harris CC: p53 mutations in human cancers. Science 253: 49-53, 1991.
16. INK4a/CDKN2A tumour suppressor and its relatives. Biochim Biophys Acta 1378: F115-F177, 1998. (Pubitemid 28530512)
17. Kiaris H and Spandidos DA: Mutations of ras genes in human tumours. Int J Oncol 7: 413-429, 1995.
18. INK4a genes in colon cancer. Lab Invest 81: 217-229, 2001. (Pubitemid 32176386)
19. Cayuela JM, Gardie B and Sigaux F: Disruption of the multiple tumour suppressor gene MTS1/p16(INK4a)/CDKN2 by illegitimate V(D)J recombinase activity in T-cell acute lymphoblastic leukemias. Blood 90: 3720-3726, 1997.
20. Cuomo CA, Mundy CL and Oettinger MA: DNA sequence and structure requirements for cleavage of V(D)J recombination signal sequences. Mol Cell Biol 16: 5683-5690, 1996.
21. Nordkvist A, Röijer E, Bang G, Gustafsson H, Behrendt M, Ryd W, Thoresen S, Donath K and Stenman G: Expression and mutation patterns of p53 in benign and malignant salivary gland tumours. Int J Oncol 16: 477-483, 2000.
22. Yamamoto Y, Wistuba II, Kishimoto Y, Virmani AK, Vuitch F, Albores-Saavedra J and Gazdar AF: DNA analysis at p53 locus in adenoid cystic carcinoma: comparison of molecular study and p53 immunostaining. Pathol Int 48: 273-280, 1998. (Pubitemid 28328307)
23. Chau Y, Hongyo T, Aozasa K and Chan JK: Dedifferentiation of adenoid cystic carcinoma: report of a case implicating p53 gene mutation. Hum Pathol 32: 1403-1407, 2001. (Pubitemid 34038678)
24. Ide F, Mishima K and Saito I: Small foci of high-grade carcinoma cells in adenoid cystic carcinoma represent an incipient phase of dedifferentiation. Histopathology 43: 604-606, 2003. (Pubitemid 38002350)
25. Sato K, Ueda Y, Sakurai A, Ishikawa Y, Kaji S, Nojima T and Katsuda S: Adenoid cystic carcinoma of the maxillary sinus with gradual histologic transformation to high-grade adenocarcinoma: a comparative report with dedifferentiated carcinoma. Virchows Arch 448: 204-208, 2006. (Pubitemid 43237887)
26. Ben-Izhak O, Laster Z, Akrish S, Muska E, Gan S and Nagler RM: The salivary tip of the p53 mutagenesis iceberg: novel insights. Cancer Biomark 5: 23-31, 2009.
27. Barbacid M: Ras genes. Annu Rev Biochem 56: 779-827, 1987.
28. INK4A: structural characterization of wild-type and mutant proteins by NMR and circular dichroism. Biochemistry 35: 9475-9478, 1996.
29. Clanton DJ, Lu YY, Blair DG and Shih TY: Structural significance of the GTP-binding domain of ras p21 studied by site-directed mutagenesis. Mol Cell Biol 7: 3092-3097, 1987.
30. Forbes SA, Bhamra G, Bamford S, Dawson E, Kok C, Clements J, Menzies A, Teague JW, Futreal PA and Stratton MR: The Catalogue of Somatic Mutations in Cancer (COSMIC). Curr Protoc Hum Genet, Chapter 10: Unit 10.11, 2008.